CardioExchange Archive

CardioExchange, an NEJM practice community for medical professionals dedicated to improving cardiac patient care, was active from 2009 to 2015. CardioExchange fostered discussion between clinicians from across the globe.

December 24th, 2010

A Look Back at 2010

CardioExchange invited a wide range of members−researchers, teachers, private practice clinicians, and fellows−to give us their impressions of the most important developments in cardiology in 2010. We summarize their lists here and offer a running scorecard. Click the authors’ names to read the full posts.  The same CardioExchange members offered predictions for 2011, and you can see a summary of those here. Also, for comparison, check out the AHA list of the top 10 advances in cardiovascular research this year.
What would your choices have been? Any sins of inclusion or exclusion here in your opinion? Join the conversations.
Steven E Nissen, MD
1. Rosiglitazone withdrawal in Europe and restriction in the U.S.
2. Approval of dabigatran
3. ACCORD lipid study
JoAnne M. Foody, MD
1. ACCORD Lipid
2. ACCORD BP
3. Meta-analysis of statins in high-risk primary prevention and all-cause mortality.
Roger Blumenthal, MD
1. Approval of dabigatran
2. JUPITER/Meta-analysis of women from prevention trials study of women with high CRP or dyslipidemia
3. ACCORD BP and ACCORD Lipids
Richard A. Lange, MD, MBA and L. David Hillis, MD
1. CREST trial (Stenting versus Endarterectomy for Treatment of Carotid-Artery Stenosis)
2. PARTNER trial (Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery)
3. COGENT trial (Clopidogrel with or without Omeprazole in Coronary Artery Disease).
Deepak L. Bhatt, MD, MPH
1. PARTNER trial (Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery)
2. RAFT (Resynchronization–Defibrillation for Ambulatory Heart Failure Trial)
3. DEFINE trial (Determining the Efficacy and Tolerability of CETP Inhibition with Anacetrapib)
John Brush, MD
1. PARTNER trial (Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery)
2. The Symplicity HTN-2 trial
3. DEFINE trial (Determining the Efficacy and Tolerability of CETP Inhibition with Anacetrapib)
John Mandrola, MD
1. Approval of dabigatran
2. Mark Midei story (Maryland doctor accused of implanting hundreds of unnecessary stents)
3. Percutaneous therapy for valvular heart disease (most notably the PARTNER trial)
Thad F Waites, MD
1. Approval of dabigratran
2. Passage of the Patient Protection and Affordable Care Act
3. Mark Midei story (Maryland doctor accused of implanting hundreds of unnecessary stents)
Barry M. Massie, MD
1. Aldosterone antagonists continue their winning streak (RALES, EPHESUS, and EMPHASIS)
2. Migrating cardiac resynchronization therapy (CRT) into milder heart failure (RAFT)
3. Disappointing data on remote monitoring to improve heart-failure outcomes (Tele-HF and TIM-HF)
John Ryan, MD
1. Study on effects of CYP2C19 genotype on outcomes of clopidogrel treatment
2. PARTNER study (Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery)
3. Studies showing risk of low-dose ionizing radiation from medical imaging procedures
James De Lemos, MD
1. ACGME releases new duty hour rules
2. Aldosterone antagonists continue their winning streak with publication of EMPHASIS-HF
3. The merging of cardiology practices and hospitals.

*** Vote Tally ***
VOTES TOPIC
5 PARTNER trial
4 Dabigatran approval
3 ACCORD Lipid
2 ACCORD BP
2 RAFT trial
2 Risk related to low-dose ionizing radiation from medical imaging
2 Mark Midei story (doctor accused of implanting unnecessary stents)
2 Aldosterone/EMPHASIS trial
1 JUPITER substudy in women
1 Meta-analysis of statins for high-risk primary prevention in women
1 CYP2C19 genotype/clopidogrel resistance study
1 DEFINE trial
1 Rosiglitazone restrictions
1 Healthcare reform
1 Remote monitoring of HF patients (Tele-HF and TIM-HF)
1 Study on effects of CYP2C19 genotype on outcomes of clopidogrel treatment
1 New ACGME duty hour rules
1 Merging of cardiology practices and hospitals
1 COGENT trial
1 CREST trial

Categories: General
Tags:


You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

Comments are closed.